Scribe Therapeutics (NASDAQ:SCTX) Major Shareholder Bio Fund Ii L.P. Ah Buys 333,333 Shares of Stock

Scribe Therapeutics Inc. (NASDAQ:SCTX - Get Free Report) major shareholder Bio Fund Ii L.P. Ah bought 333,333 shares of the stock in a transaction on Monday, July 27th. The shares were acquired at an average cost of $15.00 per share, for a total transaction of $4,999,995.00. Following the purchase, the insider owned 2,385,075 shares in the company, valued at $35,776,125. The trade was a 16.25% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.

Scribe Therapeutics Stock Up 1.7%

Shares of NASDAQ SCTX opened at $18.36 on Thursday. Scribe Therapeutics Inc. has a 52 week low of $17.31 and a 52 week high of $25.49.

Read More

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Scribe Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Scribe Therapeutics and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles